STOCK TITAN

Zoetis to Participate in the Barclays Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Zoetis Inc. (ZTS) to participate in the Barclays Global Healthcare Conference on March 14, 2024. Wetteny Joseph, CFO, to represent the company. Live webcast and replay available for investors.
Positive
  • None.
Negative
  • None.

PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 14, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 8:30 a.m. ET.

Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

About Zoetis

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com.

ZTS-COR
ZTS-IR

Media Contacts:

Jenielle Alonso

1-973-945-4333 (o)

jenielle.alonso@zoetis.com



Laura Panza

1-973-975-5176 (o)

laura.panza@zoetis.com

Investor Contacts:

Steve Frank

1-973-822-7141 (o)

steve.frank@zoetis.com



Nick Soonthornchai

1-973-443-2792 (o)

nick.soonthornchai@zoetis.com

Source: Zoetis Inc.

Zoetis Inc. (ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 14, 2024.

Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent Zoetis Inc. at the conference.

Wetteny Joseph is scheduled to present at 8:30 a.m. ET at the Barclays Global Healthcare Conference.

Investors and other interested parties can access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations.

Yes, a replay of the presentation will be available on the Zoetis website at the conclusion of the event.
Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Generic, Manufacturing, Pharmaceutical Preparation Manufacturing
US
Parsippany

About ZTS

Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.